相关产品推荐更多 >

Fibroblast Antibody, anti-human, PE-Vio® 615, REAfinity™, 100 tests in 200 µL
询价
CD61 Antibody, anti-mouse/rat, Vio® Bright V423, REAfinity™, 30 µg in 200 µL
询价
CD94 Antibody, anti-mouse, PE-Vio® 615, REAfinity™, 150 µg in 1 mL
询价
CD229 (Ly-9) Antibody, anti-mouse, APC, REAfinity™, 9 µg in 300 µL
询价
Integrin β5 Antibody, anti-human, Vio® Bright FITC, REAfinity™, 100 tests in 200 µL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
TRA-1-60
- 亚型:
recombinant human IgG1
- 形态:
Antibodies are supplied in phosphate-buffered saline (PBS), pH 7.2. The product contains no preservative and is sterile filtered. Always handle under aseptic conditions.
- 保存条件:
避光,2-8℃
- 克隆性:
REA157
- 标记物:
Vio 488
- 适应物种:
human
- 保质期:
24个月
- 供应商:
Miltenyi Biotec
- 宿主:
human cell line
- 应用范围:
Flow cytometry, Immunocytochemistry
- 抗体英文名:
TRA-1-60 Antibody, anti-human, REAfinity™
- 抗体名:
TRA-1-60 Antibody, anti-human, REAfinity™
- 规格:
100 µL
Detection of TRA-1-60+ cells in cell cultureClone REA157 recognizes the TRA-1-60 antigen, a neuraminidase-resistant carbohydrate epitope expressed on podocalyxin, which is a transmembrane glycoprotein. Podocalyxin is a member of the CD34-related family of sialomucins and is recognized as a stem cell and tumor marker. TRA-1-60 antigen is expressed on the surface of human embryonic stem cells (ESC), embryonic germ cells (EG), and embryonic carcinoma cells (EC). Expression of TRA-1-60 is lost upon differentiation and thus it can be used to assess the differentiation stage of the cells. TRA-1-60 can be detected in the serum of patients with germ cell tumors which contain an EC component. | Additional information: Clone REA157 displays negligible binding to Fc receptors. |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Andrews, P. W. et al. (1984) Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 3 (4): 347–361. | Lajer, H. et al. (2002) Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer. Int. J. Cancer 100 (2): 244–246. | Schopperle, W. M. et al. (2007) The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells 25 (3): 723–730.
技术资料暂无技术资料 索取技术资料
文献支持
TRA-1-60 Antibody, anti-human, Vio® 488, REAfinity™, 100 µL
询价





